Cheng Z.J. et al.

2019 Novel coronavirus : where we are and what we know

Infection, 2020; doi/org/101007/s15010-020-01401-y

Cassone A. et al.

Relationship between SARS-2-COV, ACE 2 and antihypertensives

Ahed of print

Moore J.B. et al

Cytokine release syndrome in severe COVID-19

Li R. et al.

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Science, May 2020; doi: 10.1126/science.abb3221

Letter to the Editor

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

NEJM, March 2020; doi: 10.1056/nejmc2004973

Lyon study group on Covid-19 infection

Wilder-Smith A. et al.

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Lancet Infect Dis., May 2020; doi: 10.1016/S1473-3099(20)30129-8

Sjödin H. et al.

Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020.

Euro Surveill., April 2020; doi: 10.2807/1560-7917.ES.2020.25.13.2000280

Salzberger B. et al.

Clerkin K.J. et al.

Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease.

Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046941

Vardeny O. et al.

Applying the Lessons of Influenza to Coronavirus During a Time of Uncertainty.

Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046837

Interim guidance

Zhao J et al.

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Clinical Infectious Diseases, April 2020; doi:10.1093/cid/ciaa414

Xiang F. et al

Antibody detection and dynamic characteristics in patients with COVID-19

Clinical Infectious Diseases, April 2020; doi: 10.1093/cid/ciaa461

Petherick A.

Henry B.M. et al.

Hematologic, biochemical and immune biomarker abnormalities associated

with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.

Clin Chem Lab Med., April 2020; doi: 10.1515/cclm-2020-0369

Chen X. et al.

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients.

Bhimraj A. et al

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.

Disponibile online at https://www.idsociety.org/COVID19guidelines

Grein J et al.

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

N Engl J Med., April 2020; doi: 10.1056/NEJMoa2007016

Lythgoe M.P. et al.